Press Releases

Latest

H1 2019 Results
25 July 2019
Update on US regulatory decision for Farxiga in type-1 diabetes
15 July 2019
Imfinzi granted US Orphan Drug Designation for small cell lung cancer
12 July 2019
Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data
1 July 2019
Fasenra receives positive EU CHMP opinion for self-administration and the new Fasenra pen, a pre-filled, single-use auto-injector
1 July 2019
Imfinzi improves overall survival at interim analysis in the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
27 June 2019
Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease
19 June 2019
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
19 June 2019
Bevespi Aerosphere approved by the Japanese Ministry of Health, Labour and Welfare for patients with chronic obstructive pulmonary disease
19 June 2019
Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer
18 June 2019

Can't find what you are looking for? Our Press Release archive contains all of our press releases dated before 2018 so you should be able to find just what you are looking for.

Explore archive

Contact us

Gonzalo Viña

Head of Global Media Relations

+44 203 749 5916

Rob Skelding

Director Global Media Relations

+44 203 749 5821

Matthew Kent

Director Global Media Relations

+44 203 749 5906

Rebecca Einhorn

Director Global Media Relations

+1 301 398 1802

Jennifer Hursit

Manager Global Media Relations

+442037495762

Christina Malmberg Hägerstrand

Media Relations Director, Sweden and Nordic-Baltic

+46 8 552 53 106

Lotta Sjösten

Manager Media Relations, Sweden

+46 8 553 271 10

US Media Team

+1 302 885 2677

Press Releases

Contact us

Subscribe

Follow us

LinkedIn